News

DRL's management has guided for double-digit growth in FY26, with margins expected to remain similar to FY25 levels. Here's ...
A MOTHER has revealed that she was unhappy and tired of dieting so decided to start using Mounjaro. In just 16 weeks, thanks to the injections, Jade-Jo was able to lose 2 stone 4 lbs. But Jade-Jo ...
Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.
Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...
After nearly 18 years on medication to manage her high blood pressure, Charity Wischmeyer, 51, is now discussing with her ...
With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention. Helen Coffey speaks to the dentists warning that jabs could have a worrying im ...
Q2 2025 Results Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSam Fisch - Executive Director, Investor Relations ...
The company’s blockbuster drugs helped it beat Wall Street’s expectations—while WeightWatchers declares bankruptcy. One day ...
A man is suing the manufacturers of Ozempic, alleging the diabetes drug caused him to go blind. The medication, containing ...
Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...